CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

Clinical trial NCT07015801 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07015801
Sponsor: University of Calgary
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cytomegalovirus Viremia Cytomegalovirus Pneumonia T-Lymphocyte Immunodeficiency

Start date: 2025-04-15
Primary completion: 2027-04-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.